An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Dades bibliogràfiques
Autor principal:	Bristy, Israt Zerin
Altres autors:	Kabir, Md. Tanvir
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2021
Matèries:	Covid-19 Lung carcinoma Genetic mutation Chemotherapy Immunotherapy Lungs > Cancer Oncology
Accés en línia:	http://hdl.handle.net/10361/15619

Ítems similars

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
per: Shabnam, Musharrat
Publicat: (2018)

Immunotherapy in the Management of Lung Cancer
per: Tasnim, Humayra
Publicat: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
per: Paul, Pulock
Publicat: (2024)

Potential of liposomes for the treatment of lung cancer- a review
per: Mim, Shanzida
Publicat: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
per: Jeba, Joynob
Publicat: (2017)

A review on recent advances in drugs for lung cancer treatment
per: Noor, Fouzia
Publicat: (2024)

A review on targeted therapies for lung cancer
per: Ashraf, Anushey
Publicat: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
per: Zangmo, Thinley
Publicat: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
per: Tania, Umme
Publicat: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
per: Rahman, Tasnim
Publicat: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
per: Razna, Amrin Islam
Publicat: (2019)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
per: Hoque, Ismoth Ara
Publicat: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
per: Mukti, Roushney Fatima, et al.
Publicat: (2016)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

Immunotherapy in the treatment of renal cancer
per: Shimu, Sumaya
Publicat: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
per: Das, Reshita
Publicat: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

Lung cancer detection and classification using machine learning
per: Arefin, Mahbubul, et al.
Publicat: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
per: Nandy, Aditi
Publicat: (2022)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
per: F. S. Amaral, André, et al.
Publicat: (2017)

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A localized drug delivery approach to treat peritoneal carcinomatosis of different origins
per: Afrin, Sabrina
Publicat: (2023)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
per: Auvy, Akib Al Mahmud, et al.
Publicat: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Karim, Samia Binte
Publicat: (2024)

Deep 3D convolutional neural network in early detection of Lung cancer
per: Hossain, Khandoker Jobayer, et al.
Publicat: (2019)

A review on CRISPR-Cas system based applications in Oncology
per: Sadia, Mir
Publicat: (2022)

Smart biomedical device to predict lung diseases, COVID-19 and diabetes by using machine learning algorithms
per: Hossain, Ashraful, et al.
Publicat: (2024)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
per: Rithin, Rafia Islam
Publicat: (2022)

Hypothesizing precise cancer treatments based on patient survival using machine learning & deep learning
per: Sakib, Hasibul, et al.
Publicat: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
per: Mirza, Maisa Tasnim
Publicat: (2023)

CAR-T cell Therapy in B-cell Lymphoma
per: Faruk, Asef
Publicat: (2020)

Effect of passive immunization with mouse Anti-BCG 64 kDa protein on ehrlich ascites carcinoma cells
per: Chowdhury, Maisha Mosharrat
Publicat: (2018)

Dendritic cell vaccine for the treatment of cancer
per: Haque, Tanzila
Publicat: (2023)

Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
per: Monayem, Kazi Fahim
Publicat: (2024)

The uses of bacteria in cancer therapy
per: Saha, Shimul, et al.
Publicat: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
per: Rahman, Samia
Publicat: (2022)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
per: Raihan, Dilraj
Publicat: (2024)